- Home
- NVNO vs EPIX Comparison
NVNO vs EPIX Comparison
Compare NVNO & EPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVNO
- EPIX
- Stock Information
- Founded
- NVNO 1987
- EPIX 2009
- Country
- NVNO United States
- EPIX Canada
- Employees
- NVNO N/A
- EPIX N/A
- Industry
- NVNO Medical/Dental Instruments
- EPIX Biotechnology: Pharmaceutical Preparations
- Sector
- NVNO Health Care
- EPIX Health Care
- Exchange
- NVNO Nasdaq
- EPIX Nasdaq
- Market Cap
- NVNO 71.0M
- EPIX 75.9M
- IPO Year
- NVNO N/A
- EPIX N/A
- Fundamental
- Price
- NVNO $4.10
- EPIX N/A
- Analyst Decision
- NVNO
- EPIX Hold
- Analyst Count
- NVNO 0
- EPIX 3
- Target Price
- NVNO N/A
- EPIX $2.00
- AVG Volume (30 Days)
- NVNO 145.2K
- EPIX 57.6K
- Earning Date
- NVNO 07-30-2025
- EPIX 08-04-2025
- Dividend Yield
- NVNO N/A
- EPIX N/A
- EPS Growth
- NVNO N/A
- EPIX N/A
- EPS
- NVNO N/A
- EPIX N/A
- Revenue
- NVNO N/A
- EPIX N/A
- Revenue This Year
- NVNO N/A
- EPIX N/A
- Revenue Next Year
- NVNO N/A
- EPIX N/A
- P/E Ratio
- NVNO N/A
- EPIX N/A
- Revenue Growth
- NVNO N/A
- EPIX N/A
- 52 Week Low
- NVNO $2.03
- EPIX $1.40
- 52 Week High
- NVNO $6.48
- EPIX $7.88
- Technical
- Relative Strength Index (RSI)
- NVNO 51.11
- EPIX 50.49
- Support Level
- NVNO $3.90
- EPIX $1.67
- Resistance Level
- NVNO $4.06
- EPIX $1.73
- Average True Range (ATR)
- NVNO 0.26
- EPIX 0.04
- MACD
- NVNO -0.06
- EPIX -0.00
- Stochastic Oscillator
- NVNO 19.61
- EPIX 55.56
About NVNO enVVeno Medical Corporation
enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.
About EPIX ESSA Pharma Inc.
ESSA Pharma Inc is a pharmaceutical company. The company was focused on the development of small-molecule drugs for the treatment of castration-resistant prostate cancer. It was developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival. Currently, the company has terminated its clinical trials and other studies.